US Patent Issued to Alnylam Pharmaceuticals on Dec. 2 for "Solute carrier family member iRNA compositions and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,512, issued on Dec. 2, was assigned to Alnylam Pharmaceuticals Inc. (Cambridge, Mass.).

"Solute carrier family member iRNA compositions and methods of use thereof" was invented by Lucas D. Ward (Cambridge, Mass.), Ho-Chou Tu (Cambridge, Mass.), James D. McIninch (Cambridge, Mass.) and Paul Nioi (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to RNAi agents, e.g., double stranded RNA (dsRNA) agents, targeting a solute carrier family member gene, e.g., SLC30A10, or SLC39A8. The invention also relates to methods of using such RNAi agents to inhibit expression of a solute carrier family member gene, e.g., an...